CPIX ROA | Cumberland Pharmaceuticals Inc.

CUMBERLAND PHARMACEUTICALS INC ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

CUMBERLAND PHARMACEUTICALS INC roa for the quarter ending 2026-06-30 was -17.36%, a change of -13.05% year-over-year.
CUMBERLAND PHARMACEUTICALS INC roa for the quarter ending 2026-03-31 was -10.40%, a change of -5.71% year-over-year.
CUMBERLAND PHARMACEUTICALS INC roa for the quarter ending 2025-12-31 was -3.69%, a change of 4.88% year-over-year.
CUMBERLAND PHARMACEUTICALS INC roa for the quarter ending 2025-09-30 was -5.05%, a change of 9.11% year-over-year.
CUMBERLAND PHARMACEUTICALS INC roa for fiscal 2025 was -3.69%, a change of 4.88% from fiscal 2024.
CUMBERLAND PHARMACEUTICALS INC roa for fiscal 2024 was -8.57%, a change of -0.89% from fiscal 2023.
CUMBERLAND PHARMACEUTICALS INC roa for fiscal 2023 was -7.68%, a change of -1.68% from fiscal 2022.
CUMBERLAND PHARMACEUTICALS INC roa for fiscal 2022 was -5.99%, a change of -1.84% from fiscal 2021.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical ROA

Date	ROA	Net income 12 month	Net income 3 month	Total assets
2026-06-30	-17.36%	-$10.92M	-$4.28M	$62.88M
2026-03-31	-10.40%	-$7.38M	-$3.29M	$71M
2025-12-31	-3.69%	-$2.84M	-$1.41M	$76.82M
2025-09-30	-5.05%	-$3.33M	-$1.94M	$65.9M
2025-06-30	-4.32%	-$2.93M	-$740.74K	$67.91M
2025-03-31	-4.68%	-$3.28M	$1.26M	$69.94M
2024-12-31	-8.57%	-$6.48M	-$1.90M	$75.58M
2024-09-30	-14.16%	-$10.87M	-$1.54M	$76.75M
2024-06-30	-13.21%	-$10.38M	-$1.09M	$78.52M
2024-03-31	-10.33%	-$8.42M	-$1.95M	$81.51M
2023-12-31	-7.68%	-$6.28M	-$6.29M	$81.78M
2023-09-30	-2.76%	-$2.43M	-$1.05M	$87.75M
2023-06-30	-2.00%	-$1.78M	$872.20K	$89.38M
2023-03-31	-4.46%	-$3.99M	$192.18K	$89.47M
2022-12-31	-5.99%	-$5.57M	-$2.44M	$92.93M
2022-09-30	-7.69%	-$6.98M	-$408.64K	$90.78M
2022-06-30	-8.24%	-$7.62M	-$1.34M	$92.52M
2022-03-31	-5.23%	-$5.06M	-$1.39M	$96.7M
2021-12-31	-4.15%	-$3.51M	-$3.85M	$84.46M
2021-09-30	-0.62%	-$543,666.00	-$1.06M	$87.57M
2021-06-30	0.03%	$29,875.00	$1.23M	$88.85M
2021-03-31	-2.27%	-$2.12M	$166.83K	$93.35M
2020-12-31	-3.46%	-$3.34M	-$883.78K	$96.46M
2020-09-30	-3.56%	-$3.42M	-$481.74K	$96.01M
2020-06-30	-5.01%	-$4.89M	-$918.27K	$97.52M
2020-03-31	-4.64%	-$4.52M	-$1.06M	$97.42M
2019-12-31	-3.38%	-$3.54M	-$960.71K	$104.55M
2019-09-30	-4.62%	-$4.8M	-$1.95M	$103.77M
2019-06-30	-4.17%	-$4.49M	-$549.51K	$107.55M
2019-03-31	-4.06%	-$4.66M	-$73.88K	$114.62M
2018-12-31	-6.18%	-$6.96M	-$2.22M	$112.69M
2018-09-30	-6.34%	-$5.54M	-$1.64M	$87.43M
2018-06-30	-5.13%	-$4.64M	-$720.69K	$90.44M
2018-03-31	-9.97%	-$9.08M	-$2.38M	$91.09M
2017-12-31	-8.56%	-$7.98M	-$800.54K	$93.23M
2017-09-30	-8.77%	-$7.93M	-$743.03K	$90.35M
2017-06-30	-8.06%	-$7.08M	-$5.16M	$87.8M
2017-03-31	-2.14%	-$1.97M	-$1.27M	$91.86M
2016-12-31	-1.01%	-$944,683.00	-$749.69K	$93.4M
2016-09-30	-0.05%	-$43,930.00	$106.17K	$91.07M
2016-06-30	-0.03%	-$23,483.00	-$48.04K	$87.89M
2016-03-31	0.48%	$430,559.00	-$253.11K	$89.21M
2015-12-31	0.79%	$729,951.00	$151.06K	$91.92M
2015-09-30	1.36%	$1.25M	$126.61K	$92.06M
2015-06-30	2.01%	$1.87M	$407.40K	$92.92M
2015-03-31	2.37%	$2.18M	$46.28K	$92.19M
2014-12-31	2.54%	$2.42M	$668.91K	$95.41M
2014-09-30	0.27%	$254,447.00	$745.92K	$93.9M
2014-06-30	-1.40%	-$1.31M	$722.57K	$93.47M
2014-03-31	-2.93%	-$2.67M	$286.32K	$91.11M
2013-12-31	-2.40%	-$2.1M	-$1.50M	$87.61M
2013-09-30	1.31%	$1.2M	-$819.94K	$91.91M
2013-06-30	4.08%	$3.89M	-$639.02K	$95.47M
2013-03-31	6.38%	$6.27M	$854.71K	$98.28M
2012-12-31	5.93%	$5.84M	$1.81M	$98.59M
2012-09-30	5.11%	$4.95M	$1.87M	$96.93M
2012-06-30	5.17%	$4.93M	$1.74M	$95.38M
2012-03-31	5.67%	$5.36M	$423.21K	$94.57M
2011-12-31	5.92%	$5.66M	$911.66K	$95.52M
2011-09-30	5.81%	$5.58M	$1.85M	$96.08M
2011-06-30	5.02%	$4.74M	$2.18M	$94.58M

Annual ROA

Date	ROA	Net income 12 month	Total assets
2025-12-31	-3.69%	-$2.84M	$76.82M
2024-12-31	-8.57%	-$6.48M	$75.58M
2023-12-31	-7.68%	-$6.28M	$81.78M
2022-12-31	-5.99%	-$5.57M	$92.93M
2021-12-31	-4.15%	-$3.51M	$84.46M
2020-12-31	-3.46%	-$3.34M	$96.46M
2019-12-31	-3.38%	-$3.54M	$104.55M
2018-12-31	-6.18%	-$6.96M	$112.69M
2017-12-31	-8.56%	-$7.98M	$93.23M
2016-12-31	-1.01%	-$944,683.00	$93.4M
2015-12-31	0.80%	$731,351.00	$91.92M
2014-12-31	2.54%	$2.42M	$95.41M
2013-12-31	-2.40%	-$2.1M	$87.61M
2012-12-31	5.93%	$5.84M	$98.59M
2011-12-31	5.92%	$5.66M	$95.52M
2010-12-31	2.67%	$2.46M	$92.05M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aardvark Therapeutics, Inc. (AARD)	United States	$0.121B	-1.80
Coya Therapeutics, Inc. (COYA)	United States	$0.121B	-6.35
OnKure Therapeutics, Inc. (OKUR)	United States	$0.119B	-3.13
INOVIO PHARMACEUTICALS, INC. (INO)	United States	$0.125B	-1.35
IMMUNIC, INC. (IMUX)	United States	$0.127B	-1.88
Immuneering Corp (IMRX)	United States	$0.113B	-12.51
Quantum Cyber N.V. (QUCY)		$0.113B
MEDICINOVA INC (MNOV)	United States	$0.130B	-6.04
BICYCLE THERAPEUTICS PLC (BCYC)		$0.112B	-1.56
NRX Pharmaceuticals, Inc. (NRXP)	United States	$0.131B	-6.31